What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Neuron
Bruno J. Gonzalez mainly focuses on Cerebellum, Receptor, Cell biology, Internal medicine and Endocrinology.
His study in the fields of Cerebellar cortex under the domain of Cerebellum overlaps with other disciplines such as Granule cell.
His work on Receptor deals in particular with Vasoactive intestinal peptide and Neuropeptide.
In general Vasoactive intestinal peptide study, his work on Pituitary adenylate cyclase-activating peptide often relates to the realm of Endocrine gland, thereby connecting several areas of interest.
His work is dedicated to discovering how Cell biology, Apoptosis are connected with Neuroprotection and other disciplines.
His work in Somatostatin receptor and Somatostatin are all subfields of Internal medicine research.
His most cited work include:
- Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions (1013 citations)
- PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. (167 citations)
- Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts. (158 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Cerebellum, Receptor and Granule cell.
In his study, Fetal alcohol syndrome and Angiogenesis is inextricably linked to Fetus, which falls within the broad field of Internal medicine.
Bruno J. Gonzalez works mostly in the field of Endocrinology, limiting it down to topics relating to Pituitary adenylate cyclase-activating peptide and, in certain cases, Molecular biology, as a part of the same area of interest.
His Cerebellum study combines topics from a wide range of disciplines, such as Neurite, Central nervous system and Cell biology.
His study looks at the intersection of Cell biology and topics like Apoptosis with Neuroprotection.
His Receptor research is multidisciplinary, relying on both Neurogenesis and Binding site.
He most often published in these fields:
- Internal medicine (50.76%)
- Endocrinology (50.00%)
- Cerebellum (37.88%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (50.76%)
- Endocrinology (50.00%)
- NMDA receptor (6.82%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Endocrinology, NMDA receptor, Angiogenesis and Neuroprotection are his primary areas of study.
His research is interdisciplinary, bridging the disciplines of Fetus and Internal medicine.
In his research, Bruno J. Gonzalez performs multidisciplinary study on Endocrinology and Intracerebral hemorrhage.
His NMDA receptor research incorporates themes from Glutamate receptor, Glutamatergic, Cell biology and Cortex, Neuroscience.
The concepts of his Cortex study are interwoven with issues in Receptor, Matrix metalloproteinase and GRIN1.
The Neuroprotection study combines topics in areas such as Lesion and GABAergic.
Between 2013 and 2021, his most popular works were:
- Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP mice (22 citations)
- PLGF , a placental marker of fetal brain defects after in utero alcohol exposure (21 citations)
- Optimization of a liquid chromatography ion mobility-mass spectrometry method for untargeted metabolomics using experimental design and multivariate data analysis (18 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Neuron
Bruno J. Gonzalez mostly deals with Angiogenesis, Pharmacology, Neuroprotection, NMDA receptor and Endocrinology.
Bruno J. Gonzalez has included themes like Fetal alcohol syndrome, Tyrosine kinase and Programmed cell death in his Angiogenesis study.
His work carried out in the field of Pharmacology brings together such families of science as Neuroendocrine tumors, Viability assay, Pheochromocytoma, CD31 and Sunitinib.
His work in Neuroprotection covers topics such as GABAergic which are related to areas like gamma-Aminobutyric acid and Glutamate receptor.
Bruno J. Gonzalez usually deals with NMDA receptor and limits it to topics linked to Glutamatergic and Ex vivo, ATG5, Excitotoxicity, Developmental profile and Antagonist.
His work focuses on many connections between Endocrinology and other disciplines, such as Internal medicine, that overlap with his field of interest in In utero.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
